Implantable Drug Eluting Devices Industry to Reach USD 19.3 Billion by 2029 at a 6.0% of CAGR

The global implantable drug eluting devices market is projected to grow at a compound annual growth rate (CAGR) of 6.0% from 2022 to 2029, expanding from its estimated valuation of USD 12.8 billion in 2022. This growth is driven by the rising demand for targeted and controlled drug delivery systems, offering enhanced treatment efficacy across …

Implantable Drug-Eluting Devices Market is Anticipated to Expand at a 6.0% CAGR and Reach USD 19.3 Billion by 2029 | FMI Research

The battle against chronic diseases is gaining a powerful ally: Implantable Drug-Eluting Devices Market. These innovative medical technologies are revolutionizing patient care by providing sustained drug delivery. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the global market for these devices is poised for significant growth, reaching a …